NPCE

Joel Becker

Known title: CHIEF EXECUTIVE OFFICERCIK: 0001533175

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 25, 2026

Keybanc Initiates Coverage on NeuroPace (NPCE) with Overweight Rating. Keybanc has started coverage of NeuroPace, giving it an overweight rating and a price target of $18. This follows the recent average analyst target of $20, which sits near the top of the 52‑week range of $9.22 to $19.60. The new rating adds to the company's positive outlook as it trades near its support level of $14.01 with an RSI of 41.9.

this person other insiders at NPCE

Transaction History

NPCE▼ Sell$19K
NPCE▼ Sell$16K
NPCE▼ Sell$20K
NPCE▼ Sell$19K
NPCE▲ Buy$0
NPCE▼ Sell$69K
NPCE▼ Sell$16K
NPCE▼ Sell$19K
NPCE▼ Sell$10K
NPCE▼ Sell$14K
NPCE▲ Buy$0
NPCE▼ Sell$57K
NPCE▲ Buy$0

We use analytics to understand how market-wall is used. No personal data is sold.